Go JOSS!
Yes, the cost is excruciating and beyond excessive.
Given that every submission can be preceded by multiple bioRxiv versions and followed by a definitive PubMed Central version that was reviewed (perhaps embargoed for 6-12 months), who actually pays these charges?
I suspect this is a theoretical charge in most cases. The exception might be for those who are compelled to provide immediate unfettered access to their work.